Jiangxi Synergy Pharmaceutical Co 300636.SZ · CNY

Its shares trade on Shenzhen under the ticker 300636.SZ. It has been listed since 31 March 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥828.7m and net income of CN¥73.1m. At that date it held total assets of CN¥3.32bn and shareholders' equity of CN¥2.37bn.

Jiangxi Synergy Pharmaceutical Co., Ltd. engages in the research and development, production and sale of chemical raw materials, active pharmaceutical ingredient and pharmaceutical intermediates. The company is headquartered in Yichun, Jiangxi. The company went IPO on 2017-03-31. The firm is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The firm's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The firm's products are sold to domestic and foreign markets, including Europe, North America and Japan.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Zhengwei PangChairman of the Board, General Manager, since 2005CN¥754,800
• Mr. Chung Shing LeungVice Chairman of the Board, Deputy General Manager, since 2005CN¥500,900
• Mr. Jinqiao HuFinance DirectorCN¥333,300
• Mr. Zhicheng ZhouDeputy General Manager, Secretary of the Board, since 2015CN¥469,500
• Mr. Guojun HuangDeputy General Manager, Director, since 2015CN¥493,500
• Mr. Yuansen JiangDeputy General Manager, Director, since 2005CN¥494,600
• Mr. Huigang JiangDirectorCN¥348,100
• Mr. Xiaohua WangDirectorCN¥398,500
• Mr. Guofeng ChenIndependent DirectorCN¥60,000
• Mr. Dingdai PengIndependent DirectorCN¥60,000
• Mr. Chuyi YuIndependent DirectorCN¥60,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.